Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-006272
Filing Date
2025-02-27
Accepted
2025-02-27 16:01:15
Documents
1
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 7899
  Complete submission text file 0001140361-25-006272.txt   9455
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address
Schwartz Jonathan David (Reporting) CIK: 0001726398 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 25678507